Cecilie Krogh

Statistics

Publications

Citations

197

H-Index

Active since

1985

Affiliations

Bayer (Norway)(Current)

Oslo University Hospital

Aalborg University

Norwegian Cancer Society

Cecilie Krogh is an author at Bayer (Norway) specializing in cancer immunotherapy, disability discrimination in selection, and disability discrimination in hiring.

ORCID

Publications per year

1985–2022

Publications

Preparation of TH <sup>227</sup> -Labeled Radioimmunoconjugates, Assessment of Serum Stability and Antigen Binding Ability

Roy H. Larsen, Jostein Dahle, Katrine B. Melhus et al. · Cancer Biotherapy and Radiopharmaceuticals · 2007 · 48 citations

Pharmacy, Immunology, Pharmaceutical Biotechnology +17

Treatment of HER2-Expressing Breast Cancer and Ovarian Cancer Cells With Alpha Particle-Emitting 227Th-Trastuzumab

Helèn Heyerdahl, Cecilie Krogh, Jørgen Borrebæk et al. · International Journal of Radiation Oncology*Biology*Physics · 2011 · 42 citations

Medicine, Oncology, Pharmacology +16

A checklist system for critical review of medical literature

Cecilie Krogh · Medical Education · 1985 · 38 citations

Education, Family Medicine, Medical Education +12

Disability Disqualifies: A Vignette Experiment on Danish Employers’ Intentions to Hire Applicants with Physical Disabilities

Ditte Shamshiri-Petersen, Cecilie Krogh · Scandinavian Journal of Disability Research · 2020 · 30 citations · Full text

Law, Employment Law, Psychology +14

In Vitro Cytotoxicity of Low-Dose-Rate Radioimmunotherapy by the Alpha-Emitting Radioimmunoconjugate Thorium-227–DOTA–Rituximab

Jostein Dahle, Cecilie Krogh, Katrine B. Melhus et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 22 citations

Medicine, Immunology, Oncology +14

1–5 of 6